Fielder Capital Group »

Regeneron Pharmaceuticals shares owned by Fielder Capital Group

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Fielder Capital Group from 13F filings

Historical chart of Fielder Capital Group investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Fielder Capital Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Fielder Capital Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $250k 260 962.49
2023-12-31 $232k 264 878.29

More positions owned by Fielder Capital Group

Ishares Gold Tr Ishares New (IAU)
Global X Fds Global X Copper (COPX)
Bitwise Bitcoin Etf Tr Shs Ben Int
Select Sector Spdr Tr Energy (XLE)
Ishares Msci Glb Slv&mtl (SLVP)
Global X Fds Glb X Mlp Enrg I (MLPX)
Grayscale Bitcoin Tr Btc Shs Rep Com Ut (GBTC)
Texas Pacific Land Corp (TPL)
Sprott Fds Tr Uranium Miners E (URNM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vaneck Etf Trust Gold Miners Etf (GDX)
Vaneck Etf Trust Junior Gold Mine (GDXJ)
Sprott Physical Silver Tr Tr Unit (PSLV)
NVIDIA Corporation (NVDA)
American Centy Etf Tr Us Eqt Etf (AVUS)

View all positions for Fielder Capital Group

Top funds holding Regeneron Pharmaceuticals

FMR
Vanguard Group
BlackRock
Jpmorgan Chase & Co
Geode Capital Management
Dodge & Cox
Franklin Resources
Morgan Stanley
Loomis, Sayles and
Wellington Management Company
Amundi
Northern Trust
Legal & General Group
Bank of America Corporation
T. Rowe Price Associates

View all funds holding Regeneron Pharmaceuticals